|
⚲
|
| Keyboard |
| Neurotrope Bioscience Inc
✚
|
|
|---|---|
| CIK # | 0001571934 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 10-K | [0001571934] | |
| 10-Q | [0001571934] | |
| 3 | [0001571934] | |
| 4 | [0001571934] | |
| 5 | [0001571934] | |
| 8-K | [0001571934] | |
| D | [0001571934] | |
| SC 13G | [0001571934] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Alpha Capital Anstalt | Synaptogenix Inc | [2021-07-07] |
| Intracoastal Capital LLC | Synaptogenix Inc | [2021-06-25] |
| Hewlett Fund LP | Synaptogenix Inc | [2021-04-30] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Singer William S | |
| Neurotrope Bioscience Inc | |
| Weinstein Robert | |
| Ephron Robert | |
| Silverman Joshua | |
| Bernstein Bruce | |
| Tuchman Alan J | |
| Schechter Jonathan | |
| Alkon Daniel L | |
| Perry George |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Neurotrope Bioscience Inc TAOX
Common Stock, par value $0.0001 per share
|
2025-10-17 | Grant | 25,000 | $0.00 | |
|
Neurotrope Bioscience Inc TAOX
Common Stock, par value $0.0001 per share
|
2025-10-17 | Grant | 15,000 | $0.00 | |
|
Neurotrope Bioscience Inc TAOX
Common Stock, par value $0.0001 per share
|
2025-10-17 | Tax withheld | 4,000 | $7.23 | 28,920 |
|
Neurotrope Bioscience Inc TAOX
Common Stock, par value $0.0001 per share
|
2025-10-17 | Tax withheld | 6,000 | $7.23 | 43,380 |
|
Neurotrope Bioscience Inc TAOX
Common Stock, par value $0.0001 per share
|
2025-10-17 | Grant | 100,000 | $0.00 | |
|
Neurotrope Bioscience Inc TAOX
Common Stock, par value $0.0001 per share
|
2025-10-17 | Grant | 10,000 | $0.00 | |
|
Neurotrope Bioscience Inc TAOX
Common Stock, par value $0.0001 per share
|
2025-10-17 | Tax withheld | 40,000 | $7.23 | 289,200 |
|
Neurotrope Bioscience Inc TAOX
Common Stock, par value $0.0001 per share
|
2025-10-17 | Grant | 7,500 | $0.00 | |
|
Neurotrope Bioscience Inc TAOX
Common Stock, par value $0.0001 per share
|
2025-10-17 | Tax withheld | 3,000 | $7.23 | 21,690 |
|
Neurotrope Bioscience Inc TAOX
Common Stock, par value $0.0001 per share
|
2025-10-17 | Tax withheld | 10,000 | $7.23 | 72,300 |
|
Neurotrope Bioscience Inc TAOX
Employee Stock Option (right to buy) · derivative
|
2025-08-06 | Grant | 12,000 | $0.00 | |
|
Neurotrope Bioscience Inc TAOX
Employee Stock Option (right to buy) · derivative
|
2025-08-06 | Grant | 2,000 | $0.00 | |
|
Neurotrope Bioscience Inc TAOX
Employee Stock Option (right to buy) · derivative
|
2025-08-06 | Grant | 7,000 | $0.00 | |
|
Neurotrope Bioscience Inc TAOX
Employee Stock Option (right to buy) · derivative
|
2025-08-06 | Grant | 7,000 | $0.00 | |
|
Neurotrope Bioscience Inc TAOX
Employee Stock Option (right to buy) · derivative
|
2025-08-06 | Grant | 36,000 | $0.00 | |
|
Neurotrope Bioscience Inc TAOX
Employee Stock Option (right to buy) · derivative
|
2025-08-06 | Grant | 10,000 | $0.00 | |
|
Neurotrope Bioscience Inc TAOX
Common Stock, par value $0.0001 per share
|
2025-06-30 | Grant | 15,410 | $0.00 | |
|
Neurotrope Bioscience Inc TAOX
Common Stock, par value $0.0001 per share
|
2025-06-30 | Tax withheld | 6,164 | $7.85 | 48,387 |
|
Neurotrope Bioscience Inc TAOX
Common Stock, par value $0.0001 per share
|
2025-06-30 | Tax withheld | 6,164 | $7.85 | 48,387 |
|
Neurotrope Bioscience Inc TAOX
Common Stock, par value $0.0001 per share
|
2025-06-30 | Grant | 15,410 | $0.00 | |
| showing 20 of 68 most recent transactions | |||||